Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
44.85
+0.41 (0.92%)
May 30, 2025, 2:45 PM CST

Hangzhou Biotest Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
138.62169.52106.61773.63833.59435.15
Upgrade
Depreciation & Amortization
22.6222.6229.1723.2510.535.48
Upgrade
Other Amortization
0.110.110.10.080.10.1
Upgrade
Loss (Gain) From Sale of Assets
0.330.33-0-00.07
Upgrade
Asset Writedown & Restructuring Costs
--6.3518.78--0.03
Upgrade
Loss (Gain) From Sale of Investments
-7.05-7.05-3.38-14.85-1.07-0.07
Upgrade
Provision & Write-off of Bad Debts
3.523.523.67-5.593.213.22
Upgrade
Other Operating Activities
1311.0536.27-48.3729.3822.57
Upgrade
Change in Accounts Receivable
-39.78-39.78-13.57107.84-51.4-69.62
Upgrade
Change in Inventory
3.133.13-14.14-48.93-60.84-60.89
Upgrade
Change in Accounts Payable
-43.09-43.09-20.43-98.94145.05107.95
Upgrade
Change in Other Net Operating Assets
6.536.532.465.311.052.56
Upgrade
Operating Cash Flow
99.87128.83131.38703.21908.12446.07
Upgrade
Operating Cash Flow Growth
-51.98%-1.94%-81.32%-22.56%103.58%1637.91%
Upgrade
Capital Expenditures
-86.84-245.05-56.42-178.92-200.2-57.68
Upgrade
Sale of Property, Plant & Equipment
0.080.080.18--1.54
Upgrade
Investment in Securities
-54.82-601.82126.76260.84-400-
Upgrade
Other Investing Activities
11.168.543.8414.790.230.07
Upgrade
Investing Cash Flow
-130.42-838.2574.3696.71-599.97-56.08
Upgrade
Short-Term Debt Issued
--0.24-5.5628.63
Upgrade
Total Debt Issued
--0.24-5.5628.63
Upgrade
Short-Term Debt Repaid
--0.15--5.29-11-49.64
Upgrade
Long-Term Debt Repaid
--2.45-4.17-2.8-2.46-
Upgrade
Total Debt Repaid
-2.6-2.6-4.17-8.08-13.46-49.64
Upgrade
Net Debt Issued (Repaid)
-2.6-2.6-3.93-8.08-7.9-21.01
Upgrade
Issuance of Common Stock
24.8724.874.17-856.14-
Upgrade
Repurchase of Common Stock
-43.18-43.18-14.76---
Upgrade
Common Dividends Paid
-136.85-83.65-234.67-320.01-20.91-100.38
Upgrade
Other Financing Activities
40.68---4.56-14.09-3.53
Upgrade
Financing Cash Flow
-117.09-104.55-249.19-332.65813.24-124.92
Upgrade
Foreign Exchange Rate Adjustments
9.2810.510.89104.91-14.82-17.7
Upgrade
Net Cash Flow
-138.35-803.48-32.55572.181,107247.36
Upgrade
Free Cash Flow
13.04-116.2374.96524.29707.92388.38
Upgrade
Free Cash Flow Growth
---85.70%-25.94%82.27%-
Upgrade
Free Cash Flow Margin
2.55%-20.78%16.95%27.58%38.94%44.88%
Upgrade
Free Cash Flow Per Share
0.12-1.100.704.918.174.86
Upgrade
Cash Income Tax Paid
0.64-0.273.48143.6367.9252.69
Upgrade
Levered Free Cash Flow
-79.34-173.95-18279.64443.47281.82
Upgrade
Unlevered Free Cash Flow
-79.33-173.93-17.91279.77443.89282.11
Upgrade
Change in Net Working Capital
70.9725.53-6.6135.1-32.83-5.33
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.